scholarly article | Q13442814 |
P50 | author | Mary Carrington | Q29840699 |
Stephen Gange | Q37372235 | ||
Melissa Fazzari | Q61099538 | ||
Norah A Terrault | Q61478982 | ||
Howard D Strickler | Q89146137 | ||
Chloe L Thio | Q92964327 | ||
James J Goedert | Q92964334 | ||
Kathryn M. Anastos | Q100301637 | ||
Howard L. Minkoff | Q111569766 | ||
Mardge H. Cohen | Q112651887 | ||
Xiaojiang Gao | Q114576939 | ||
Darlene Marti | Q115623850 | ||
Mark H Kuniholm | Q115623853 | ||
P2093 | author name string | Xiaonan Xue | |
Marion G Peters | |||
Mary A Young | |||
Ruth M Greenblatt | |||
Andrea Kovacs | |||
Tiffany G Harris | |||
P2860 | cites work | A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci | Q21145042 |
Influence of MHC class II genotype on outcome of infection with hepatitis C virus. The HENCORE group. Hepatitis C European Network for Cooperative Research | Q22010973 | ||
HLA-Cw*04 and hepatitis C virus persistence | Q27472874 | ||
The natural course of hepatitis C virus infection after 22 years in a unique homogenous cohort: spontaneous viral clearance and chronic HCV infection | Q27477855 | ||
Interaction of NK inhibitory receptor genes with HLA-C and MHC class II alleles in Hepatitis C virus infection outcome | Q27486089 | ||
Host Genetic Factors and Antiviral Immune Responses to Hepatitis C Virus | Q27487445 | ||
Human leukocyte antigen class II associations with hepatitis C virus clearance and virus‐specific CD4 T cell response among Caucasians and African Americans | Q27489728 | ||
Determinants of viral clearance and persistence during acute hepatitis C virus infection | Q28131757 | ||
Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS | Q28198471 | ||
A comparative review of HLA associations with hepatitis B and C viral infections across global populations | Q28299722 | ||
A whole-genome association study of major determinants for host control of HIV-1 | Q29614891 | ||
The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 | ||
The global burden of hepatitis C | Q29620138 | ||
Identification of two independent risk factors for lupus within the MHC in United Kingdom families | Q30837981 | ||
Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. | Q34056087 | ||
HLA class II association with rheumatoid arthritis: facts and interpretations | Q34132727 | ||
Evidence for human leukocyte antigen heterozygote advantage against hepatitis C virus infection | Q34700869 | ||
Evaluating the impact of hepatitis C virus (HCV) on highly active antiretroviral therapy-mediated immune responses in HCV/HIV-coinfected women: role of HCV on expression of primed/memory T cells | Q35077992 | ||
Protective effect of human leukocyte antigen B27 in hepatitis C virus infection requires the presence of a genotype-specific immunodominant CD8+ T-cell epitope | Q35404598 | ||
Host genetic determinants in hepatitis C virus infection | Q35753723 | ||
Hanging in the balance. KIR and their role in disease. | Q36241147 | ||
Hepatitis C virus quasispecies in HIV-infected women: role of injecting drug use and highly active antiretroviral therapy (HAART) | Q36427909 | ||
Impact of the genetic restriction of virus-specific T-cell responses in hepatitis C virus infection | Q36710738 | ||
Genetic factors affecting the occurrence, clinical phenotype, and outcome of autoimmune hepatitis | Q37105244 | ||
High sensitivity of human leukocyte antigen-b*5701 as a marker for immunologically confirmed abacavir hypersensitivity in white and black patients | Q37150304 | ||
A comparison between the force of infection estimates for blood-borne viruses in injecting drug user populations across the European Union: a modelling study. | Q40052601 | ||
Do we still need a cohort study of women with HIV infection? | Q40866620 | ||
Meta-analysis of the association between HLA-DRB1 allele and rheumatoid arthritis susceptibility in Asian populations. | Q41575362 | ||
Spontaneous viral clearance, viral load, and genotype distribution of hepatitis C virus (HCV) in HIV-infected patients with anti-HCV antibodies in Europe | Q42981324 | ||
Hepatitis C virus (HCV)--specific T cell responses in injection drug users with apparent resistance to HCV infection | Q42982614 | ||
Distinct MHC class I and II alleles are associated with hepatitis C viral clearance, originating from a single source | Q42986139 | ||
HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection | Q42986755 | ||
Persistence of hepatitis C virus in a white population: associations with human leukocyte antigen class 1. | Q42986786 | ||
Association between MHC class II alleles and clearance of circulating hepatitis C virus. Members of the Trent Hepatitis C Virus Study Group | Q42988856 | ||
Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group | Q42993140 | ||
Increased frequency of the HLA-DR15 (B1*15011) allele in German patients with self-limited hepatitis C virus infection. | Q42993377 | ||
Viral clearance in hepatitis C (1b) infection: relationship with human leukocyte antigen class II in a homogeneous population | Q42998786 | ||
Study of host- and virus-related factors associated with spontaneous hepatitis C virus clearance | Q43000404 | ||
Outcome of acute hepatitis C is related to virus-specific CD4 function and maturation of antiviral memory CD8 responses. | Q43000889 | ||
Racial differences in HLA class II associations with hepatitis C virus outcomes | Q43032027 | ||
Protective effect of HLA-B57 on HCV genotype 2 infection in a West African population | Q43038195 | ||
Influence of human leukocyte antigen-DRB1 on the susceptibility and severity of rheumatoid arthritis | Q44037409 | ||
Influence of HLA haplotypes on the clinical courses of individuals infected with hepatitis C virus | Q44258227 | ||
Extended human leukocyte antigen haplotype EH18.1 influences progression to hepatocellular carcinoma in patients with hepatitis C virus infection. | Q44785802 | ||
Absence of association between HLA antigens and chronicity of viral hepatitis in haemodialyzed patients | Q44944774 | ||
The HLA-B*5703 allele confers susceptibility to the development of spondylarthropathies in Zambian human immunodeficiency virus-infected patients with slow progression to acquired immunodeficiency syndrome. | Q45527277 | ||
Rapid transmission of hepatitis C virus among young injecting heroin users in Southern China | Q45654072 | ||
Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection | Q45759756 | ||
HLA class II genes in chronic hepatitis C virus-infection and associated immunological disorders | Q45766137 | ||
Major histocompatibility complex class I chain-related gene A in Thai psoriasis patients: MICA association as a part of human leukocyte antigen-B-Cw haplotypes | Q47614377 | ||
Human leukocyte antigen allele associations in type-1 autoimmune hepatitis patients from western India. | Q54682881 | ||
HLA-B*5703 independently associated with slower HIV-1 disease progression in Rwandan women. | Q55033318 | ||
Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. | Q55240560 | ||
Association between MHC Class II Alleles and Clearance of Circulating Hepatitis C Virus | Q58324423 | ||
HLA class II favors clearance of HCV infection and progression of the chronic liver damage | Q60023612 | ||
Meta-analysis and epidemiologic studies in drug development and postmarketing surveillance | Q74592836 | ||
Association between HLA class II genotype and spontaneous clearance of hepatitis C viraemia | Q77169966 | ||
Natural history of hepatitis C | Q80384219 | ||
AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis | Q81481381 | ||
The Women's Interagency HIV Study. WIHS Collaborative Study Group | Q95805016 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | hepatitis C | Q154869 |
Hepatitis C virus | Q708693 | ||
P304 | page(s) | 1514-1522 | |
P577 | publication date | 2010-05-01 | |
P1433 | published in | Hepatology | Q15724398 |
P1476 | title | Specific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremia | |
P478 | volume | 51 |
Q36609717 | Acute and Chronic Hepatitis E Virus Infection in Human Immunodeficiency Virus-Infected U.S. Women |
Q37805839 | Adaptive Immunity to the Hepatitis C Virus |
Q35350883 | Additive effects of HLA alleles and innate immune genes determine viral outcome in HCV infection |
Q59351582 | Approaches, Progress, and Challenges to Hepatitis C Vaccine Development |
Q40943814 | Association of HLA class II alleles with hepatitis C virus clearance and persistence in thalassemia patients from Iran |
Q36921188 | Association of Hepatitis C Virus Infection With CD4/CD8 Ratio in HIV-Positive Women |
Q42605390 | Characterisation of Mhc class I and class II DRB polymorphism in red-bellied tamarins (Saguinus labiatus). |
Q35531173 | Compensatory mutations restore the replication defects caused by cytotoxic T lymphocyte escape mutations in hepatitis C virus polymerase |
Q38010203 | Complete definition of immunological correlates of protection and clearance of hepatitis C virus infection: a relevant pending task for vaccine development |
Q34369562 | DLA class II alleles and haplotypes are associated with risk for and protection from chronic hepatitis in the English Springer spaniel |
Q27010312 | Dendritic Cells in HIV-1 and HCV Infection: Can They Help Win the Battle? |
Q37540482 | Detection of HCV-Specific IFN-γ Responses in HCV Antibody and HCV RNA Negative Injecting Drug Users |
Q46500540 | Differential Immunodominance Hierarchy of CD8+ T-Cell Responses in HLA-B*27:05- and -B*27:02-Mediated Control of HIV-1 Infection |
Q43047331 | Early Transcriptional Divergence Marks Virus-Specific Primary Human CD8+ T Cells in Chronic versus Acute Infection |
Q33796039 | Effect of HLA on hepatitis C virus clearance and persistence in anti-HCV-positive end-stage renal disease patients |
Q58091936 | Exploring NS3/4A, NS5A and NS5B proteins to design conserved subunit multi-epitope vaccine against HCV utilizing immunoinformatics approaches |
Q37964746 | Failure of innate and adaptive immune responses in controlling hepatitis C virus infection |
Q33350754 | Genes and hepatitis C: susceptibility, fibrosis progression and response to treatment. |
Q83885557 | Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma |
Q30590832 | Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts |
Q45352716 | HLA DRB1 alleles and hepatitis C virus infection in chronic kidney disease patients. |
Q36221533 | HLA Preferences for Conserved Epitopes: A Potential Mechanism for Hepatitis C Clearance. |
Q35374519 | HLA-B alleles B*15:01 and B*15:02: opposite association with hepatitis C virus infection in Chinese voluntary blood donors |
Q37402195 | HLA-B*27 subtype specificity determines targeting and viral evolution of a hepatitis C virus-specific CD8+ T cell epitope |
Q43037903 | Hepatitis C virus replication in Caucasian HIV controllers. |
Q38812892 | Hepatitis C-A clinical review |
Q61443480 | High prevalence of occult hepatitis C infection in predialysis patients |
Q37862746 | Host genetics in immune-mediated hepatitis C virus clearance |
Q41935509 | Human Leukocyte Antigen Variants and Risk of Hepatocellular Carcinoma Modified by HCV Genotypes: A Genome-wide Association Study |
Q39255932 | Human leucocyte antigen class I and II imputation in a multiracial population. |
Q35446259 | Human leukocyte antigen B27 selects for rare escape mutations that significantly impair hepatitis C virus replication and require compensatory mutations |
Q35275215 | Human leukocyte antigen genotype and risk of HIV disease progression before and after initiation of antiretroviral therapy |
Q57285391 | Identification of a Shared Cytochrome p4502E1 Epitope Found in Anesthetic Drug-Induced and Viral Hepatitis |
Q36594965 | Immunity and hepatitis C: a review |
Q37281576 | Influence of IFNL3 and HLA-DPB1 genotype on postpartum control of hepatitis C virus replication and T-cell recovery |
Q38364524 | Innate and adaptive genetic pathways in HCV infection |
Q55311659 | KIR2DL2 combined with HLA-C1 confers risk of hepatitis C virus-related hepatocellular carcinoma in younger patients. |
Q34055276 | KIR2DL2 enhances protective and detrimental HLA class I-mediated immunity in chronic viral infection |
Q37354049 | Mapping the genomic diversity of HCV subtypes 1a and 1b: Implications of structural and immunological constraints for vaccine and drug development |
Q52626860 | Regulatory CD4+ T Cells Recognize MHC-II-Restricted Peptide Epitopes of Apolipoprotein B. |
Q37046078 | Relation of HLA class I and II supertypes with spontaneous clearance of hepatitis C virus |
Q42978256 | Reversal of nonstructural protein 3-specific CD4(+) T cell dysfunction in patients with persistent hepatitis C virus infection |
Q37957971 | Role of stress-induced NKG2D ligands in liver diseases. |
Q34493947 | Spontaneous control of HCV is associated with expression of HLA-B 57 and preservation of targeted epitopes |
Q35737580 | Survival and HLA-B*57 in HIV/HCV Co-Infected Patients on Highly Active Antiretroviral Therapy (HAART). |
Q37138377 | Synergism of tapasin and human leukocyte antigens in resolving hepatitis C virus infection |
Q27003510 | T cell responses in hepatitis C virus infection: historical overview and goals for future research |
Q37166509 | The Associations of HLA-A*02:01 and DRB1*11:01 with Hepatitis C Virus Spontaneous Clearance Are Independent of IL28B in the Chinese Population |
Q34181287 | The efficiency of the human CD8+ T cell response: how should we quantify it, what determines it, and does it matter? |
Q35000910 | The relation of HLA genotype to hepatitis C viral load and markers of liver fibrosis in HIV-infected and HIV-uninfected women |
Q28391462 | The role of HLA-DR-DQ haplotypes in variable antibody responses to anthrax vaccine adsorbed |
Q35839496 | Update on hepatitis C virus-specific immunity |
Q64122751 | Vaccination to prevent T cell subversion can protect against persistent hepacivirus infection |
Search more.